We are live on ! Find out more
DG

Davidson & Garrard Portfolio holdings

AUM $425M
1-Year Est. Return 14.62%
This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+14.62%
3 Year Est. Return
+25.19%
5 Year Est. Return
10 Year Est. Return
AUM
$417M
AUM Growth
+$14.5M
Cap. Flow
-$718K
Cap. Flow %
-0.17%
Top 10 Hldgs %
20.94%
Holding
196
New
8
Increased
74
Reduced
82
Closed
9

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$763K
2
INVN
Invensense Inc
INVN
+$733K
3
PSEC icon
Prospect Capital
PSEC
+$658K
4
LKQ icon
LKQ Corp
LKQ
+$552K
5
BAC icon
Bank of America
BAC
+$472K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$721K
2
DLN icon
WisdomTree US LargeCap Dividend Fund
DLN
+$685K
3
TPR icon
Tapestry
TPR
+$465K
4
PEP icon
PepsiCo
PEP
+$414K
5
DRI icon
Darden Restaurants
DRI
+$393K

Sector Composition

Rank Sector Weight
1 Healthcare 13.52%
2 Technology 13.08%
3 Financials 10.77%
4 Industrials 9.01%
5 Energy 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.79T
$12.4M 2.97%
531,980
-7,160
-1% -$152K
GE icon
2
GE Aerospace
GE
$354B
$9.61M 2.31%
76,286
+90
+0.1% +$11.4K
VZ icon
3
Verizon
VZ
$185B
$9.52M 2.28%
194,465
+1,870
+1% +$90.6K
PFF icon
4
iShares Preferred and Income Securities ETF
PFF
$13.3B
$9.46M 2.27%
237,008
+6,686
+3% +$264K
AMJ
5
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$8.88M 2.13%
169,460
-6,788
-4% -$334K
XOM icon
6
ExxonMobil
XOM
$640B
$8.59M 2.06%
85,294
-397
-0.5% -$40K
CVS icon
7
CVS Health
CVS
$138B
$8.37M 2.01%
111,018
-717
-0.6% -$54.2K
TMO icon
8
Thermo Fisher Scientific
TMO
$196B
$7.02M 1.68%
59,464
-1,787
-3% -$210K
T icon
9
AT&T
T
$160B
$6.79M 1.63%
254,313
+1,473
+0.6% +$39.5K
PEP icon
10
PepsiCo
PEP
$185B
$6.65M 1.6%
74,457
-4,797
-6% -$414K
MCK icon
11
McKesson
MCK
$95.3B
$6.42M 1.54%
34,501
-1,570
-4% -$279K
PG icon
12
Procter & Gamble
PG
$347B
$6.11M 1.47%
77,731
-471
-0.6% -$38K
INTC icon
13
Intel
INTC
$516B
$6M 1.44%
194,296
-2,626
-1% -$72K
NNN icon
14
NNN REIT
NNN
$9.32B
$5.92M 1.42%
159,088
-1,116
-0.7% -$39.2K
IBM icon
15
IBM
IBM
$193B
$5.88M 1.41%
33,955
-4,005
-11% -$721K
SE
16
DELISTED
Spectra Energy Corp Wi
SE
$5.88M 1.41%
138,472
-8,060
-6% -$323K
IWM icon
17
iShares Russell 2000 ETF
IWM
$81.6B
$5.88M 1.41%
49,477
-2,345
-5% -$266K
SLB icon
18
SLB Ltd
SLB
$71.3B
$5.84M 1.4%
49,551
-1,485
-3% -$153K
BDX icon
19
Becton Dickinson
BDX
$42.2B
$5.72M 1.37%
49,545
-801
-2% -$90.8K
ESRX
20
DELISTED
Express Scripts Holding Company
ESRX
$5.62M 1.35%
81,053
-1,737
-2% -$122K
JNJ icon
21
Johnson & Johnson
JNJ
$615B
$5.54M 1.33%
52,984
-2,998
-5% -$303K
MCHP icon
22
Microchip Technology
MCHP
$46.2B
$5.53M 1.33%
226,640
-2,296
-1% -$54.7K
SDY icon
23
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$5.41M 1.3%
70,590
-2,088
-3% -$156K
JPM icon
24
JPMorgan Chase
JPM
$926B
$5.32M 1.28%
92,252
+730
+0.8% +$41K
BAC icon
25
Bank of America
BAC
$432B
$5.3M 1.27%
344,892
+30,381
+10% +$472K

Similar funds

Davidson & Garrard's Q2 2014 Portfolio in Review

As of Q2 2014, Davidson & Garrard held 196 positions worth $417M, up 3.6% from $402M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Davidson & Garrard's Q2 2014 filing shows 8 new, 74 increased, 82 reduced and 9 closed positions. Its largest new stake was Nike: 20,514 shares worth $795K. The largest sale was IBM, an estimated $721K.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

  • Davidson & Garrard's largest Q2 2014 buy was Nike: 20,514 shares worth $795K.
  • Davidson & Garrard added most to Invensense Inc in Q2 2014, an estimated $733K increase.
  • Davidson & Garrard's biggest Q2 2014 reduction was IBM, cutting an estimated $721K.
  • Davidson & Garrard fully exited WisdomTree US LargeCap Dividend Fund in Q2 2014, selling an estimated $685K.
  • Davidson & Garrard's ten largest holdings make up 21% of its $417M portfolio in Q2 2014.
  • Davidson & Garrard opened 8 new positions and closed 9 in Q2 2014.
  • Davidson & Garrard's portfolio value rose 3.6% quarter-over-quarter to $417M.

Based on Davidson & Garrard's 13F filing for Q2 2014, filed 7 Aug 2014.